(Q34071577)

30 July 2017

1 reference

title

Colony stimulating factors in patients with fever and neutropenia (English)

1 reference

30 July 2017

Rubenstein EB

1

1 reference

30 July 2017

language of work or name

1 reference

1 October 2000

1 reference

International Journal of Antimicrobial Agents

30 July 2017

published in

1 reference

30 July 2017

volume

16

1 reference

30 July 2017

issue

2

1 reference

30 July 2017

page(s)

117-121

1 reference

Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900214-4

7 January 2021

Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900214-4

7 January 2021

Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900214-4

7 January 2021

Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900214-4

7 January 2021

Improving treatment of chemotherapy-induced neutropenic fever by administration of colony-stimulating factors

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900214-4

7 January 2021

Filgrastim in patients with chemotherapy-induced febrile neutropenia. A double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900214-4

7 January 2021

Results of a randomized trial of granulocyte colony-stimulating factor in patients with infection and severe granulocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900214-4

7 January 2021

Granulocyte colony-stimulating factor in established febrile neutropenia: a randomized study of pediatric patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900214-4

7 January 2021

Randomized comparison between antibiotics alone and antibiotics plus granulocyte-macrophage colony-stimulating factor (Escherichia coli-derived in cancer patients with fever and neutropenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900214-4

7 January 2021

Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900214-4

7 January 2021

American Society of Clinical Oncology. Recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900214-4

7 January 2021

Decision analysis of hematopoietic growth factor use in patients receiving cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900214-4

7 January 2021

Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900214-4

7 January 2021

A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900214-4

7 January 2021

Oral versus Intravenous Empirical Antimicrobial Therapy for Fever in Patients with Granulocytopenia Who Are Receiving Cancer Chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900214-4

7 January 2021

Feasibility of outpatient management of fever in cancer patients with low-risk neutropenia: results of a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900214-4

7 January 2021

10.1016/S0924-8579(00)00214-4

Identifiers

DOI

1 reference

30 July 2017

1 reference